Navigation Links
eResearchTechnology (eRT) Agrees to Acquire the Centralized ECG Business of Covance
Date:11/27/2007

Covance and eRT Enter into Exclusive Marketing Agreement to Offer eRT's

Cardiac Safety Services to Covance's Clients for 10 Years

PHILADELPHIA, Nov. 27 /PRNewswire-FirstCall/ -- eResearchTechnology, Inc. (eRT), (Nasdaq: ERES), a leading provider of technology and services to the pharmaceutical, biotechnology and medical device industries, announced today that it has agreed to acquire the centralized ECG business of Covance Inc. In addition, Covance and eRT have entered into an exclusive ten-year marketing agreement to supply eRT's centralized cardiac safety services to Covance's clients. It is expected that the acquisition will close on or before November 28, 2007.

"By acquiring the centralized cardiac services of Covance, eRT is furthering its commitment as a leader in the cardiac safety field. The scale, expertise, and ancillary technology benefits that will be derived from the acquisition will allow us to provide better and more cost-effective services to our valued clients and to the drug development industry," said Dr. Michael McKelvey, President and CEO of eRT. "By engaging in this long-term strategic relationship with the world's largest publicly-traded CRO, eRT is looking to extend its global leadership position in the area of cardiac safety."

"Covance remains fully committed to providing our clients with integrated drug development solutions, including critical cardiac safety data in clinical projects," said Joe Herring, Chairman and CEO of Covance. "Under the new marketing arrangement, we believe our clients will benefit from eRT's industry-leading centralized ECG services. The transaction also allows Covance's management team to focus more attention on growing our service offer
'/>"/>

SOURCE eResearchTechnology, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. eResearchTechnology, Inc. to Announce 2007 Third Quarter Results on November 1, 2007
2. Covance Agrees to Enter Strategic Relationship with eResearchTechnology to Offer its Clients eRTs Centralized Cardiac Safety Services
3. Innocoll Agrees the Sale of its CollaRx(R) GENTAMICIN SURGICAL IMPLANT and European Sales and Marketing Infrastructure to EUSA Pharma
4. Wild American Shrimp Board Agrees To Implement New Self-Funding Measures
5. Medical Services International Agrees to Retail the VScan Hepatitis B&C Test Kits in SE Asia
6. CSC Agrees to Acquire First Consulting Group
7. Cogdell Spencer Inc. Acquires Summit Professional Plaza I and II in Brunswick, Georgia
8. Omnicom Acquires Leading Healthcare Marketing Communications Firm in China
9. Food Bank For New York City Acquires FoodChange
10. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
11. Simcere Pharmaceutical Group Acquires a 51% Stake in Boda Pharmaceutical Co., Ltd.
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Anesiva Completes Sale of its Zingo(TM) Assets to Powder Pharmaceuticals and Lee's Pharmaceuticals 2St. Luke's Hospital Acquires Pioneering Technology From BrainLAB 2St. Luke's Hospital Acquires Pioneering Technology From BrainLAB 3Al Novak Elected Chairman of the Board of OrbusNeich Medical 2Xoft Expands Cancer Treatment Platform With Launch of Skin Cancer Electronic Brachytherapy Trial at AAPM Meeting 52754 1Xoft Expands Cancer Treatment Platform With Launch of Skin Cancer Electronic Brachytherapy Trial at AAPM Meeting 52754 2Xoft Expands Cancer Treatment Platform With Launch of Skin Cancer Electronic Brachytherapy Trial at AAPM Meeting 52754 3Xoft Expands Cancer Treatment Platform With Launch of Skin Cancer Electronic Brachytherapy Trial at AAPM Meeting 52754 4New Research Reveals the Majority of Parents Overlook Key Steps to Keep Curious Toddlers Safe at Home 52751 1New Research Reveals the Majority of Parents Overlook Key Steps to Keep Curious Toddlers Safe at Home 52751 2New Research Reveals the Majority of Parents Overlook Key Steps to Keep Curious Toddlers Safe at Home 52751 3New Research Reveals the Majority of Parents Overlook Key Steps to Keep Curious Toddlers Safe at Home 52751 4Driven by Launch of Emerging Therapies Overall Prostate Cancer Drug Market Will Increase by 242 Billion Through 2018 52748 1Driven by Launch of Emerging Therapies Overall Prostate Cancer Drug Market Will Increase by 242 Billion Through 2018 52748 2Driven by Launch of Emerging Therapies Overall Prostate Cancer Drug Market Will Increase by 242 Billion Through 2018 52748 3